| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myositis, Inclusion Body | 23 | 2025 | 49 | 5.410 |
Why?
|
| Amyotrophic Lateral Sclerosis | 15 | 2024 | 173 | 4.580 |
Why?
|
| Myositis | 20 | 2025 | 100 | 4.410 |
Why?
|
| Frontotemporal Dementia | 11 | 2023 | 67 | 4.310 |
Why?
|
| Charcot-Marie-Tooth Disease | 10 | 2023 | 219 | 2.030 |
Why?
|
| Drosophila Proteins | 11 | 2022 | 757 | 1.830 |
Why?
|
| Active Transport, Cell Nucleus | 6 | 2020 | 112 | 1.700 |
Why?
|
| C9orf72 Protein | 10 | 2023 | 45 | 1.670 |
Why?
|
| Muscle, Skeletal | 22 | 2025 | 973 | 1.540 |
Why?
|
| Drosophila melanogaster | 9 | 2023 | 809 | 1.400 |
Why?
|
| DNA Repeat Expansion | 7 | 2023 | 73 | 1.150 |
Why?
|
| Neurodegenerative Diseases | 2 | 2022 | 272 | 1.140 |
Why?
|
| Autoimmune Diseases | 7 | 2023 | 270 | 1.040 |
Why?
|
| Peripheral Nervous System Diseases | 4 | 2021 | 130 | 0.980 |
Why?
|
| TRPV Cation Channels | 3 | 2021 | 45 | 0.910 |
Why?
|
| Drosophila | 13 | 2023 | 767 | 0.890 |
Why?
|
| Dermatomyositis | 7 | 2023 | 34 | 0.860 |
Why?
|
| Muscular Diseases | 5 | 2023 | 116 | 0.830 |
Why?
|
| DNA-Binding Proteins | 6 | 2024 | 1891 | 0.800 |
Why?
|
| Polymyositis | 5 | 2020 | 17 | 0.800 |
Why?
|
| Autoantibodies | 8 | 2025 | 420 | 0.760 |
Why?
|
| Lysosomes | 3 | 2022 | 248 | 0.730 |
Why?
|
| Motor Neurons | 4 | 2018 | 122 | 0.730 |
Why?
|
| Neuroimaging | 2 | 2016 | 362 | 0.710 |
Why?
|
| Autophagy | 2 | 2023 | 405 | 0.700 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2020 | 11 | 0.680 |
Why?
|
| Synaptic Transmission | 5 | 2018 | 321 | 0.680 |
Why?
|
| Animals | 36 | 2025 | 33154 | 0.670 |
Why?
|
| Mutation | 11 | 2023 | 5947 | 0.650 |
Why?
|
| Animals, Genetically Modified | 7 | 2020 | 325 | 0.630 |
Why?
|
| Cell Nucleus | 3 | 2018 | 551 | 0.630 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2020 | 139 | 0.610 |
Why?
|
| Presynaptic Terminals | 3 | 2018 | 79 | 0.600 |
Why?
|
| Neuromuscular Junction | 3 | 2014 | 92 | 0.600 |
Why?
|
| Disease Models, Animal | 11 | 2025 | 4446 | 0.590 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2020 | 192 | 0.590 |
Why?
|
| Axonal Transport | 2 | 2022 | 27 | 0.570 |
Why?
|
| Calcium Signaling | 1 | 2020 | 241 | 0.570 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group F-H | 1 | 2018 | 3 | 0.570 |
Why?
|
| Transcription Factor TFIID | 2 | 2018 | 17 | 0.570 |
Why?
|
| Ataxin-2 | 1 | 2018 | 10 | 0.560 |
Why?
|
| RNA-Binding Protein FUS | 2 | 2018 | 18 | 0.560 |
Why?
|
| GTP Phosphohydrolases | 2 | 2020 | 158 | 0.550 |
Why?
|
| RNA | 4 | 2023 | 517 | 0.540 |
Why?
|
| Muscle Strength | 5 | 2023 | 79 | 0.540 |
Why?
|
| Muscle Fibers, Skeletal | 4 | 2024 | 101 | 0.530 |
Why?
|
| Mitochondrial Proteins | 2 | 2020 | 272 | 0.530 |
Why?
|
| Humans | 71 | 2025 | 127095 | 0.510 |
Why?
|
| Electromyography | 2 | 2016 | 138 | 0.500 |
Why?
|
| Syringomyelia | 1 | 2016 | 16 | 0.490 |
Why?
|
| Whole Body Imaging | 1 | 2016 | 30 | 0.490 |
Why?
|
| Nervous System Diseases | 2 | 2021 | 394 | 0.490 |
Why?
|
| Polyneuropathies | 1 | 2016 | 30 | 0.480 |
Why?
|
| Flavoproteins | 1 | 2015 | 20 | 0.480 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 283 | 0.470 |
Why?
|
| Nuclear Pore Complex Proteins | 3 | 2022 | 18 | 0.460 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2015 | 96 | 0.460 |
Why?
|
| RNA-Binding Proteins | 3 | 2018 | 532 | 0.450 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2016 | 243 | 0.430 |
Why?
|
| Neurologic Examination | 2 | 2020 | 194 | 0.420 |
Why?
|
| Proteins | 2 | 2016 | 996 | 0.410 |
Why?
|
| Peripheral Nerves | 1 | 2013 | 80 | 0.390 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2017 | 247 | 0.360 |
Why?
|
| Male | 33 | 2025 | 62658 | 0.340 |
Why?
|
| Vacuoles | 2 | 2022 | 29 | 0.320 |
Why?
|
| Calcium | 4 | 2021 | 1026 | 0.310 |
Why?
|
| Genes, Modifier | 2 | 2019 | 12 | 0.300 |
Why?
|
| Interferon-gamma | 2 | 2023 | 528 | 0.300 |
Why?
|
| Phenotype | 10 | 2023 | 4306 | 0.290 |
Why?
|
| Female | 31 | 2025 | 68483 | 0.280 |
Why?
|
| Autoantigens | 2 | 2025 | 104 | 0.270 |
Why?
|
| Neurons | 5 | 2018 | 1921 | 0.260 |
Why?
|
| Antibody Formation | 2 | 2025 | 267 | 0.260 |
Why?
|
| Mice | 12 | 2025 | 17679 | 0.240 |
Why?
|
| Longitudinal Studies | 5 | 2022 | 1431 | 0.230 |
Why?
|
| Aged | 17 | 2025 | 20431 | 0.230 |
Why?
|
| Middle Aged | 19 | 2025 | 27801 | 0.230 |
Why?
|
| Transcriptome | 5 | 2024 | 1066 | 0.220 |
Why?
|
| HIV Infections | 1 | 2017 | 1954 | 0.220 |
Why?
|
| RNA Helicases | 2 | 2023 | 75 | 0.210 |
Why?
|
| Adult | 19 | 2023 | 30435 | 0.210 |
Why?
|
| Motor Cortex | 2 | 2021 | 63 | 0.210 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 3 | 2020 | 32 | 0.200 |
Why?
|
| Young Adult | 10 | 2021 | 9694 | 0.200 |
Why?
|
| Motor Neuron Disease | 2 | 2014 | 17 | 0.200 |
Why?
|
| Proteostasis Deficiencies | 1 | 2023 | 6 | 0.200 |
Why?
|
| Creatine Kinase | 3 | 2018 | 61 | 0.200 |
Why?
|
| Nerve Degeneration | 2 | 2021 | 128 | 0.200 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2023 | 26 | 0.200 |
Why?
|
| Regeneration | 2 | 2018 | 206 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2023 | 3714 | 0.190 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2022 | 25 | 0.190 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2020 | 130 | 0.190 |
Why?
|
| Muscular Dystrophy, Oculopharyngeal | 1 | 2022 | 2 | 0.190 |
Why?
|
| Biopsy | 5 | 2025 | 1237 | 0.190 |
Why?
|
| HeLa Cells | 2 | 2021 | 684 | 0.190 |
Why?
|
| HEK293 Cells | 3 | 2021 | 770 | 0.190 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2022 | 11 | 0.190 |
Why?
|
| Cortactin | 1 | 2021 | 3 | 0.190 |
Why?
|
| Peptide Library | 1 | 2022 | 57 | 0.180 |
Why?
|
| Osteonecrosis | 1 | 2022 | 14 | 0.180 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2022 | 36 | 0.180 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2018 | 7 | 0.180 |
Why?
|
| Adenosine Triphosphatases | 1 | 2022 | 186 | 0.180 |
Why?
|
| Myocarditis | 1 | 2023 | 124 | 0.180 |
Why?
|
| Pluripotent Stem Cells | 1 | 2022 | 71 | 0.180 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 234 | 0.180 |
Why?
|
| Heterografts | 1 | 2022 | 190 | 0.170 |
Why?
|
| GTPase-Activating Proteins | 2 | 2019 | 85 | 0.170 |
Why?
|
| Muscle Weakness | 2 | 2019 | 86 | 0.170 |
Why?
|
| Neurites | 1 | 2021 | 42 | 0.170 |
Why?
|
| Bacteriophages | 1 | 2022 | 87 | 0.170 |
Why?
|
| Transcription Factors | 2 | 2023 | 2344 | 0.170 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2021 | 44 | 0.170 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2021 | 37 | 0.170 |
Why?
|
| Immunosuppressive Agents | 2 | 2023 | 654 | 0.170 |
Why?
|
| Cadherins | 1 | 2022 | 174 | 0.170 |
Why?
|
| Myelin P0 Protein | 2 | 2022 | 25 | 0.170 |
Why?
|
| Axons | 2 | 2021 | 373 | 0.170 |
Why?
|
| Cytoplasm | 2 | 2018 | 249 | 0.170 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2021 | 52 | 0.160 |
Why?
|
| Wings, Animal | 1 | 2020 | 30 | 0.160 |
Why?
|
| Nuclear Pore | 2 | 2017 | 15 | 0.160 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2020 | 414 | 0.160 |
Why?
|
| Up-Regulation | 1 | 2022 | 827 | 0.160 |
Why?
|
| Antibodies | 2 | 2022 | 352 | 0.160 |
Why?
|
| RNA, Messenger | 3 | 2023 | 2541 | 0.150 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2022 | 285 | 0.150 |
Why?
|
| Rare Diseases | 1 | 2021 | 200 | 0.150 |
Why?
|
| Inflammation | 2 | 2024 | 1433 | 0.150 |
Why?
|
| Interferon Type I | 1 | 2019 | 108 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 440 | 0.150 |
Why?
|
| Polyphenols | 1 | 2018 | 22 | 0.150 |
Why?
|
| Physical Endurance | 1 | 2018 | 42 | 0.150 |
Why?
|
| Foot | 1 | 2019 | 61 | 0.150 |
Why?
|
| Blotting, Western | 1 | 2020 | 1014 | 0.150 |
Why?
|
| Genes, Dominant | 2 | 2020 | 240 | 0.140 |
Why?
|
| alpha Karyopherins | 1 | 2018 | 6 | 0.140 |
Why?
|
| Sodium Compounds | 1 | 2018 | 9 | 0.140 |
Why?
|
| Amyloid | 1 | 2018 | 64 | 0.140 |
Why?
|
| beta Karyopherins | 1 | 2018 | 14 | 0.140 |
Why?
|
| Arsenites | 1 | 2018 | 18 | 0.140 |
Why?
|
| HLA-DRB1 Chains | 1 | 2018 | 45 | 0.140 |
Why?
|
| ran GTP-Binding Protein | 1 | 2018 | 27 | 0.140 |
Why?
|
| Mitochondria, Muscle | 1 | 2018 | 36 | 0.140 |
Why?
|
| Cells, Cultured | 2 | 2021 | 2896 | 0.140 |
Why?
|
| Cytoplasmic Granules | 1 | 2018 | 50 | 0.140 |
Why?
|
| Proteostasis | 1 | 2018 | 34 | 0.140 |
Why?
|
| Financing, Organized | 1 | 2017 | 21 | 0.140 |
Why?
|
| Trans-Activators | 1 | 2021 | 676 | 0.130 |
Why?
|
| Models, Theoretical | 1 | 2020 | 358 | 0.130 |
Why?
|
| alpha-Synuclein | 1 | 2018 | 124 | 0.130 |
Why?
|
| Aged, 80 and over | 8 | 2022 | 6695 | 0.130 |
Why?
|
| Antibodies, Antinuclear | 1 | 2017 | 31 | 0.130 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 459 | 0.130 |
Why?
|
| Muscle Cells | 1 | 2017 | 25 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2020 | 458 | 0.130 |
Why?
|
| Huntingtin Protein | 1 | 2017 | 60 | 0.130 |
Why?
|
| Calpain | 1 | 2017 | 41 | 0.130 |
Why?
|
| Signal Recognition Particle | 1 | 2016 | 11 | 0.130 |
Why?
|
| Cohort Studies | 4 | 2021 | 4972 | 0.130 |
Why?
|
| HLA Antigens | 1 | 2018 | 218 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 4509 | 0.130 |
Why?
|
| Dendrites | 1 | 2018 | 174 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2023 | 871 | 0.130 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 542 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 727 | 0.120 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 122 | 0.120 |
Why?
|
| RNA Interference | 1 | 2018 | 493 | 0.120 |
Why?
|
| Mortality, Premature | 1 | 2016 | 15 | 0.120 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2016 | 59 | 0.120 |
Why?
|
| Protein Aggregates | 1 | 2016 | 31 | 0.120 |
Why?
|
| Muscles | 3 | 2023 | 218 | 0.120 |
Why?
|
| Huntington Disease | 1 | 2017 | 140 | 0.120 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 658 | 0.120 |
Why?
|
| Membrane Glycoproteins | 1 | 2018 | 416 | 0.120 |
Why?
|
| Endosomes | 1 | 2015 | 62 | 0.120 |
Why?
|
| Edema | 1 | 2016 | 139 | 0.120 |
Why?
|
| Disease Progression | 4 | 2023 | 2118 | 0.120 |
Why?
|
| Mobility Limitation | 1 | 2015 | 32 | 0.120 |
Why?
|
| Electrophysiology | 2 | 2014 | 252 | 0.120 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 2071 | 0.110 |
Why?
|
| Open Reading Frames | 1 | 2015 | 201 | 0.110 |
Why?
|
| Mitochondria | 1 | 2020 | 727 | 0.110 |
Why?
|
| Larva | 2 | 2013 | 249 | 0.110 |
Why?
|
| Synaptotagmin II | 1 | 2014 | 8 | 0.110 |
Why?
|
| Lambert-Eaton Myasthenic Syndrome | 1 | 2014 | 9 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 377 | 0.110 |
Why?
|
| Synapses | 1 | 2018 | 432 | 0.110 |
Why?
|
| Exons | 1 | 2017 | 757 | 0.110 |
Why?
|
| Muscle Proteins | 1 | 2017 | 397 | 0.110 |
Why?
|
| Genes, Lethal | 1 | 2014 | 75 | 0.100 |
Why?
|
| Scoliosis | 1 | 2015 | 140 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 2886 | 0.100 |
Why?
|
| Cause of Death | 1 | 2016 | 487 | 0.100 |
Why?
|
| Valosin Containing Protein | 2 | 2023 | 13 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2018 | 756 | 0.100 |
Why?
|
| Genetic Therapy | 1 | 2018 | 683 | 0.100 |
Why?
|
| Hearing Loss | 1 | 2015 | 199 | 0.100 |
Why?
|
| Animal Structures | 1 | 2013 | 9 | 0.100 |
Why?
|
| Ion Channels | 1 | 2014 | 201 | 0.100 |
Why?
|
| Feasibility Studies | 1 | 2016 | 798 | 0.100 |
Why?
|
| Proteomics | 1 | 2017 | 563 | 0.100 |
Why?
|
| Dipeptides | 2 | 2023 | 64 | 0.100 |
Why?
|
| Dynactin Complex | 1 | 2012 | 4 | 0.090 |
Why?
|
| Photobleaching | 1 | 2012 | 6 | 0.090 |
Why?
|
| Brain | 4 | 2018 | 3034 | 0.090 |
Why?
|
| Sciatic Neuropathy | 1 | 2012 | 6 | 0.090 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2012 | 9 | 0.090 |
Why?
|
| Sciatic Nerve | 1 | 2012 | 48 | 0.090 |
Why?
|
| Age of Onset | 3 | 2020 | 609 | 0.090 |
Why?
|
| Models, Biological | 2 | 2018 | 1360 | 0.090 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2021 | 209 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 1711 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 133 | 0.090 |
Why?
|
| Homeostasis | 1 | 2015 | 677 | 0.090 |
Why?
|
| Biomedical Research | 1 | 2017 | 533 | 0.090 |
Why?
|
| Cytoskeletal Proteins | 1 | 2013 | 273 | 0.090 |
Why?
|
| Circadian Rhythm | 1 | 2014 | 301 | 0.090 |
Why?
|
| Membrane Potentials | 1 | 2012 | 294 | 0.090 |
Why?
|
| Protein Transport | 1 | 2012 | 349 | 0.090 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2018 | 796 | 0.080 |
Why?
|
| Sleep | 1 | 2014 | 352 | 0.080 |
Why?
|
| Amino Acid Sequence | 3 | 2022 | 2543 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 1867 | 0.080 |
Why?
|
| Severity of Illness Index | 4 | 2020 | 2991 | 0.080 |
Why?
|
| Neoplasms | 2 | 2022 | 2856 | 0.080 |
Why?
|
| Atrophy | 2 | 2023 | 238 | 0.080 |
Why?
|
| Drug Design | 1 | 2010 | 153 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2020 | 6242 | 0.080 |
Why?
|
| Double-Blind Method | 2 | 2023 | 1595 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 979 | 0.070 |
Why?
|
| Adolescent | 7 | 2021 | 20082 | 0.070 |
Why?
|
| Protein Binding | 1 | 2012 | 1662 | 0.070 |
Why?
|
| Actin Cytoskeleton | 2 | 2021 | 48 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3265 | 0.070 |
Why?
|
| Cell Line | 2 | 2021 | 2564 | 0.060 |
Why?
|
| Child, Preschool | 5 | 2020 | 14423 | 0.060 |
Why?
|
| Prevalence | 2 | 2022 | 2612 | 0.060 |
Why?
|
| Janus Kinase Inhibitors | 1 | 2025 | 27 | 0.060 |
Why?
|
| Mice, Inbred NOD | 1 | 2025 | 290 | 0.050 |
Why?
|
| Pedigree | 2 | 2021 | 1655 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2025 | 210 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2025 | 205 | 0.050 |
Why?
|
| Nuclear Proteins | 2 | 2024 | 1205 | 0.050 |
Why?
|
| Hydroxylamines | 1 | 2023 | 6 | 0.050 |
Why?
|
| Time Factors | 3 | 2020 | 6142 | 0.050 |
Why?
|
| Connexins | 1 | 2023 | 55 | 0.050 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2023 | 14 | 0.050 |
Why?
|
| Genome-Wide Association Study | 2 | 2022 | 1728 | 0.050 |
Why?
|
| Child | 6 | 2020 | 25228 | 0.050 |
Why?
|
| RNA Recognition Motif Proteins | 1 | 2023 | 18 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2024 | 361 | 0.050 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2023 | 28 | 0.050 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2023 | 83 | 0.050 |
Why?
|
| Complement System Proteins | 1 | 2023 | 57 | 0.050 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2023 | 109 | 0.050 |
Why?
|
| Sp4 Transcription Factor | 1 | 2022 | 4 | 0.050 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2022 | 4 | 0.050 |
Why?
|
| Mice, Inbred mdx | 1 | 2022 | 43 | 0.050 |
Why?
|
| Myoblasts | 1 | 2022 | 31 | 0.050 |
Why?
|
| Dystrophin | 1 | 2022 | 41 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2025 | 773 | 0.050 |
Why?
|
| Immunodominant Epitopes | 1 | 2022 | 53 | 0.050 |
Why?
|
| Interferons | 1 | 2023 | 136 | 0.050 |
Why?
|
| Muscle Development | 1 | 2022 | 67 | 0.050 |
Why?
|
| DNA Helicases | 1 | 2023 | 229 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2024 | 350 | 0.040 |
Why?
|
| Postmortem Changes | 1 | 2021 | 12 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2024 | 435 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2022 | 190 | 0.040 |
Why?
|
| Genotype | 2 | 2019 | 2598 | 0.040 |
Why?
|
| Walk Test | 1 | 2021 | 30 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2023 | 406 | 0.040 |
Why?
|
| Wheelchairs | 1 | 2020 | 17 | 0.040 |
Why?
|
| Time | 1 | 2021 | 94 | 0.040 |
Why?
|
| Virulence Factors | 1 | 2022 | 170 | 0.040 |
Why?
|
| COS Cells | 1 | 2021 | 244 | 0.040 |
Why?
|
| Walking | 1 | 2023 | 229 | 0.040 |
Why?
|
| Orthotic Devices | 1 | 2020 | 19 | 0.040 |
Why?
|
| Early Growth Response Transcription Factors | 1 | 2020 | 3 | 0.040 |
Why?
|
| Autophagosomes | 1 | 2020 | 28 | 0.040 |
Why?
|
| Mucoproteins | 1 | 2020 | 12 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 2020 | 15 | 0.040 |
Why?
|
| Protein Stability | 1 | 2021 | 161 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2022 | 231 | 0.040 |
Why?
|
| Apolipoproteins A | 1 | 2020 | 52 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2020 | 187 | 0.040 |
Why?
|
| Cell Death | 1 | 2021 | 236 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2021 | 161 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2024 | 676 | 0.040 |
Why?
|
| Arginine | 1 | 2022 | 329 | 0.040 |
Why?
|
| Genes, Recessive | 1 | 2020 | 183 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2021 | 167 | 0.040 |
Why?
|
| Heterozygote | 1 | 2022 | 690 | 0.040 |
Why?
|
| United States | 3 | 2023 | 11386 | 0.040 |
Why?
|
| Prognosis | 2 | 2020 | 4799 | 0.040 |
Why?
|
| Histones | 1 | 2023 | 503 | 0.040 |
Why?
|
| Accidental Falls | 1 | 2021 | 114 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2020 | 204 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2020 | 216 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 1399 | 0.040 |
Why?
|
| Biomarkers | 2 | 2020 | 3233 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 270 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 278 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2020 | 599 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2023 | 891 | 0.040 |
Why?
|
| Sarcomeres | 1 | 2018 | 32 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2018 | 54 | 0.040 |
Why?
|
| Myelin Proteins | 1 | 2019 | 74 | 0.040 |
Why?
|
| Neurilemmoma | 1 | 2019 | 40 | 0.040 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2018 | 27 | 0.040 |
Why?
|
| Biological Availability | 1 | 2018 | 136 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 477 | 0.030 |
Why?
|
| Protein Folding | 1 | 2018 | 214 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 372 | 0.030 |
Why?
|
| DNA Damage | 1 | 2021 | 498 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 440 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2019 | 821 | 0.030 |
Why?
|
| Chromatin | 1 | 2021 | 472 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2024 | 3322 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 61 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2022 | 17065 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 808 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2020 | 1484 | 0.030 |
Why?
|
| Machine Learning | 1 | 2020 | 325 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 358 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2017 | 292 | 0.030 |
Why?
|
| Thigh | 1 | 2016 | 50 | 0.030 |
Why?
|
| Research Personnel | 1 | 2017 | 124 | 0.030 |
Why?
|
| Necrosis | 1 | 2016 | 191 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 1379 | 0.030 |
Why?
|
| Aftercare | 1 | 2017 | 151 | 0.030 |
Why?
|
| G-Quadruplexes | 1 | 2015 | 11 | 0.030 |
Why?
|
| Australia | 1 | 2016 | 172 | 0.030 |
Why?
|
| Computational Biology | 1 | 2020 | 835 | 0.030 |
Why?
|
| Neural Conduction | 1 | 2015 | 78 | 0.030 |
Why?
|
| Risk Factors | 2 | 2022 | 10610 | 0.030 |
Why?
|
| Demyelinating Diseases | 1 | 2015 | 65 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 787 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2799 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 898 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2015 | 69 | 0.030 |
Why?
|
| Adiposity | 1 | 2016 | 203 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2017 | 439 | 0.030 |
Why?
|
| Europe | 1 | 2016 | 361 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 1483 | 0.030 |
Why?
|
| Registries | 1 | 2022 | 1537 | 0.030 |
Why?
|
| Health Surveys | 1 | 2016 | 255 | 0.030 |
Why?
|
| Risk | 1 | 2017 | 735 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2022 | 1868 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 1709 | 0.030 |
Why?
|
| Synaptic Vesicles | 1 | 2014 | 68 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1140 | 0.030 |
Why?
|
| Exocytosis | 1 | 2014 | 66 | 0.030 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2014 | 12 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 1231 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2017 | 554 | 0.030 |
Why?
|
| Hormone Antagonists | 1 | 2014 | 45 | 0.030 |
Why?
|
| CLOCK Proteins | 1 | 2014 | 34 | 0.030 |
Why?
|
| Mifepristone | 1 | 2014 | 87 | 0.030 |
Why?
|
| ARNTL Transcription Factors | 1 | 2014 | 44 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2014 | 202 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 1387 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2014 | 155 | 0.030 |
Why?
|
| Reaction Time | 1 | 2014 | 156 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 1598 | 0.030 |
Why?
|
| Vinculin | 1 | 2013 | 6 | 0.020 |
Why?
|
| Cell-Matrix Junctions | 1 | 2013 | 8 | 0.020 |
Why?
|
| Talin | 1 | 2013 | 11 | 0.020 |
Why?
|
| src Homology Domains | 1 | 2013 | 35 | 0.020 |
Why?
|
| Vibration | 1 | 2013 | 29 | 0.020 |
Why?
|
| Hearing Disorders | 1 | 2013 | 35 | 0.020 |
Why?
|
| Electrophysiological Phenomena | 1 | 2013 | 62 | 0.020 |
Why?
|
| Rats | 1 | 2019 | 3392 | 0.020 |
Why?
|
| Integrins | 1 | 2013 | 88 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2013 | 90 | 0.020 |
Why?
|
| Genome, Insect | 1 | 2013 | 80 | 0.020 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2013 | 75 | 0.020 |
Why?
|
| Alleles | 1 | 2017 | 1609 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2013 | 622 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 191 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2018 | 701 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 3502 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 2311 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 2233 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 2309 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2013 | 450 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 734 | 0.020 |
Why?
|
| Binding Sites | 1 | 2013 | 1185 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 2747 | 0.020 |
Why?
|
| Physicians | 1 | 2016 | 623 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2017 | 3716 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 3680 | 0.020 |
Why?
|
| Infant | 1 | 2020 | 12784 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 12567 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 4484 | 0.010 |
Why?
|